5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus

Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus

Gastrointestinal and peripancreatic crises present some of the most challenging hemodynamic and pain-management scenarios in veterinary emergency and critical care. Understanding the cellular cascades of autodigestion, enterotoxin-induced hyperpermeability, and mesenteric vascular torsion is paramount for the advanced critical care technician.

1. Acute Pancreatitis: Pathophysiological Cascades & SIRS

Acute Pancreatitis is initiated when protective cellular mechanisms in pancreatic acinar cells fail, leading to the premature intracellular activation of trypsinogen to trypsin:

1. Zymogen Activation Cascade: Active trypsin catalyzes the activation of other digestive zymogens (chymotrypsinogen, proelastase, prophospholipase $A_2$, and prekallikrein) within the pancreatic parenchyma.
2. Autodigestion & Local Fat Saponification: Activated enzymes break down cellular membranes, microvasculature, and peripancreatic adipose tissue. Phospholipase $A_2$ produces lysolecithin, inducing coagulative necrosis and vascular thrombosis. Local fat necrosis releases free fatty acids that bind ionized calcium, forming insoluble calcium soaps (saponification of mesenteric fat).
3. Systemic Inflammatory Response Syndrome (SIRS): Massive quantities of inflammatory cytokines (TNF-$\alpha$, IL-1, IL-6), platelet-activating factor (PAF), and active proteases spill into the systemic and portal circulation, predisposing the patient to Acute Respiratory Distress Syndrome (ARDS), Acute Kidney Injury (AKI), and Disseminated Intravascular Coagulation (DIC).

[Intra-Acinar Co-Localization of Zymogens & Lysosomes]
                         │
         Trypsinogen ──► ACTIVE TRYPSIN
                         │
    ┌────────────────────┼────────────────────┐
    ▼                    ▼                    ▼
Chymotrypsin          Elastase         Phospholipase A2
(Tissue Edema)    (Vascular Rupture)  (Coagulative Necrosis)
    │                    │                    │
    └────────────────────┬────────────────────┘
                         ▼
   Autodigestion of Pancreas & Saponification of Fat
                         │
                         ▼
   Systemic Spillover of Proteases & Cytokines (SIRS)

Canine vs. Feline Clinical Manifestations

2. Diagnostics & Multimodal Management of Pancreatitis

Diagnostic Biomarkers & Imaging

• Pancreas-Specific Lipase: Spec cPL (canine) and Spec fPL (feline) are quantitative immunoassay tests with high clinical sensitivity and specificity for acinar inflammation.
• Ionized Hypocalcemia ($iCa^{2+} < 1.0\text{ mmol/L}$): Caused by intense saponification of mesenteric fat; severe ionized hypocalcemia is a recognized negative prognostic biomarker.
• Abdominal Ultrasonography: Hallmarks include an enlarged, hypoechoic pancreas, hyperechoic peripancreatic fat (steatitis/saponification), corrugated duodenal wall, and localized peripancreatic effusion.

Modern Multimodal Intensive Management

1. Aggressive Isotonic Fluid Resuscitation: Pancreatic tissue is exquisitely vulnerable to microvascular ischemia. Administer balanced crystalloids (Plasmalyte, LRS) to maintain microvascular perfusion and prevent progression from edematous to necrotizing pancreatitis.
2. Early Enteral Nutrition: The historic practice of "resting the pancreas (NPO)" is contraindicated. Early enteral feeding via nasogastric (NG), nasoesophageal (NE), or esophagostomy (E-tube) diets maintains gut barrier integrity, prevents enterocyte atrophy, and minimizes bacterial translocation.
3. Multimodal Analgesia: Pancreatitis generates intense visceral neuropathic pain:
   • Pure $\mu$-Opioids: Methadone (0.2–0.4 mg/kg IV q4–6h) or Fentanyl CRI (2–5 mcg/kg/hr).
   • Buprenorphine: Partial $\mu$-agonist (0.02–0.03 mg/kg IV or OTM q6–8h) for feline patients.
   • Lidocaine CRI (Dogs Only): 25–50 mcg/kg/min; provides visceral analgesia, free radical scavenging, and anti-inflammatory properties.
   • Ketamine CRI: Sub-anesthetic dose (0.1–0.5 mg/kg/hr) to block NMDA-mediated central sensitization ("wind-up").
4. Antiemetics: Maropitant (1 mg/kg IV q24h) and Ondansetron (0.5 mg/kg IV q8h).

3. Acute Hemorrhagic Diarrhea Syndrome (AHDS / HGE)

Acute Hemorrhagic Diarrhea Syndrome (AHDS), formerly termed Hemorrhagic Gastroenteritis (HGE), is an acute, life-threatening disorder characterized by rapid fluid and protein loss into the intestinal lumen.

Pathophysiology & Etiology

• Enterotoxin Pore Formation: Associated with the rapid proliferation of Clostridium perfringens type A producing pore-forming enterotoxins (primarily NetF toxin and C. perfringens enterotoxin [CPE]).
• Endothelial Hyperpermeability: Toxins bind intestinal epithelial cell membranes, creating transmembrane pores that cause acute cell lysis, extreme mucosal hyperpermeability, and rapid exudation of whole blood and plasma proteins into the bowel.

[C. perfringens NetF Pore-Forming Toxin]
                  │
      Enterocyte Membrane Lysis
                  │
    ┌─────────────┴─────────────┐
    ▼                           ▼
Massive Plasma Exudation   Intestinal Mucosal Bleeding
(Intravascular Depletion)  ("Raspberry Jam" Stool)
    │                           │
    └─────────────┬─────────────┘
                  ▼
  Hallmark Diagnostic Discrepancy:
  • Profound Hemoconcentration (PCV 60-75%+)
  • Normal or Decreased Total Solids (TS 4.5-6.0 g/dL)

Hallmark Diagnostic Triad & Fluid Therapy Rules

• The Diagnostic Triad:
  1. Marked Hemoconcentration: Packed Cell Volume (PCV) typically 60% to 75%+ (often >80%).
  2. Normal or Decreased Total Solids (TS): Despite severe dehydration, TS is often normal (6.0–7.0 g/dL) or low (<5.5 g/dL) due to concurrent enteric protein-losing enteropathy.
  3. "Raspberry Jam" Feces: Sudden onset of explosive, foul-smelling hemorrhagic diarrhea.
• Fluid Resuscitation Protocol: Deliver rapid boluses of balanced isotonic crystalloids (20–30 mL/kg over 20–30 minutes), repeating until perfusion parameters normalize and PCV declines below 50%.
• Antimicrobial Stewardship: Prospective veterinary studies demonstrate that routine prophylactic antibiotic therapy is NOT indicated in uncomplicated AHDS. Antibiotics should be strictly withheld unless the patient displays overt signs of systemic sepsis or SIRS (e.g., leukopenia, bandemia, persistent pyrexia, or refractory hypotension).

4. Mesenteric Volvulus: The Ultimate Surgical Emergency

Mesenteric Volvulus is an acute, catastrophic event in which the entire intestinal tract twists (180° to 360°+) around the mesenteric root (cranial mesenteric artery).

• Pathophysiology: Rotation of the mesenteric root causes immediate, complete strangulation of the cranial mesenteric artery and mesenteric vein. This induces instantaneous, transmural hemorrhagic necrosis of the entire jejunum, ileum, and ascending colon.
• Clinical Presentation: Most commonly affects young-to-middle-aged, large-breed dogs (especially German Shepherd Dogs and Belgian Malinois). Manifests with sudden, agonizing, intractable abdominal pain, rapid abdominal distension, severe hypovolemic/obstructive and endotoxic shock, non-palpable pulses, and rapid cardiovascular collapse within hours.
• Radiography: Abdominal radiographs reveal diffuse, severe, uniform gas distension of small intestinal loops throughout the entire peritoneal cavity.
• Prognosis & Surgical Mandate: Prognosis is grave (mortality >80–90%). Survival depends on immediate emergency exploratory laparotomy, derotation, and extensive bowel resection. Extreme vigilance is required for lethal reperfusion shock and endotoxemia upon untwisting the mesenteric pedicle.